SCHEMBL28704196

SCHEMBL28704196

CCCCC1(CCCC)c2cc(C(=O)CCC3CCCCC3)ccc2-c2ccc([N+](=O)[O-])cc21

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.43
▸ ALDH1A1 P00352 4/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ KCNH2 Q12809 1/20 0.39
▸ ACHE P22303 4/20 0.39
▸ GAA P10253 1/20 0.39
▸ PTGS1 P23219 2/20 0.39
▸ PTGS2 P35354 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ HTR4 Q13639 2/20 0.37
▸ PDE4A P27815 1/20 0.36
▸ PDE4B Q07343 1/20 0.36
▸ PDE4C Q08493 1/20 0.36
▸ PDE4D Q08499 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL29503051 0.87 MAPT (0.41) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
Acetic Acid SCHEMBL22497433 0.87 MAPT (0.41) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
Acetic Acid SCHEMBL22497435 0.87 MAPT (0.41) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL21694392 0.86 MAPT (0.47) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL22497434 0.85 MAPT (0.46) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL31747787 0.85 MAPT (0.46) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL28403051 0.85 PDK2 (0.41) ACHEPTGS1PTGS2HTR4PDE4A
SCHEMBL18012796 0.85 ATM (0.39) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL18012636 0.83 ESPL1 (0.43) MAPTALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL18012751 0.80 HDAC3 (0.41) MAPTALDH1A1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4067998-B1 EO/PO MODIFIED 9-PHENYLACRIDINE PHOTOSENSITIZERS FOR USE IN PHOTOSENSITIVE RESINS IN THE MANUFACTURE OF PRINTED CIRCUIT BOARDS CHANGZHOU TRONLY NEW ELECTRONIC MAT CO LTD (CN) 2025-11-12 — — EP disclosed
US-20230167066-A1 ETHOXY/PROPOXY MODIFIED PYRAZOLINE ORGANIC MATTER, APPLICATION THEREOF, PHOTOCURABLE COMPOSITION, AND PHOTORESIST CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) 2023-06-01 — — US disclosed
EP-4140983-A1 ETHOXY/PROPOXY MODIFIED PYRAZOLINE ORGANIC MATTER, APPLICATION THEREOF, PHOTOCURABLE COMPOSITION, AND PHOTORESIST Changzhou Tronly New Electronic Materials Co., Ltd. (CN) 2023-03-01 — — EP disclosed
US-20230016182-A1 EO/PO-MODIFIED 9-PHENYLACRIDINE PHOTOSENSITIZERS AND APPLICATION THEREOF CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) 2023-01-19 — — US disclosed
WO-2022199625-A1 PHOTOSENSITIVE RESIN COMPOSITION HAVING IMPROVED SYSTEM HUE STABILITY 常州正洁智造科技有限公司 2022-09-29 — — WO disclosed
CN-114442425-A Curable resin composition, solder resist film formed from the same, interlayer insulating material, and printed wiring board 常州正洁智造科技有限公司 2022-05-06 — — CN disclosed
WO-2022089228-A1 CURABLE RESIN COMPOSITION AND SOLDER RESIST FILM FORMED THEREFROM, INTERLAYER INSULATING MATERIAL, AND PRINTED CIRCUIT BOARD 常州正洁智造科技有限公司 2022-05-05 — — WO disclosed
CN-114326299-A Photosensitive resin composition, optical filter and application 常州强力电子新材料股份有限公司 2022-04-12 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167066-A1 ETHOXY/PROPOXY MODIFIED PYRAZOLINE ORGANIC MATTER, APPLICATION THEREOF, PHOTOCURABLE COMPOSITION, AND PHOTORESIST PPOX, PLK2, CCNO MAPT 887/4885ALDH1A1 2522/4885KMT2A 1339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback